Efficacy of a Novel Fibranium Fiber Mattress Topper for Reducing Chronic Low Back Pain: A Randomized, Double-Blind, Placebo-Controlled Trial
Bibliographic record
Abstract
Chronic low back pain is a prevalent and debilitating condition, often with limited treatment options. Previous research has shown that a mattress topper containing 'Fibrilium' fibers can effectively reduce chronic low back pain. This study investigated an upgraded fiber, called "Fibranium," with enhanced composition and manufacturing, hypothesized to improve effects for pain reduction and associated parameters. The aim of this study was to evaluate the efficacy of a Fibranium fiber mattress topper for reducing pain intensity and improving function in individuals with chronic low back pain compared to a placebo topper. This prospective, randomized, double-blind, placebo-controlled trial was conducted with 54 patients (aged 40-70 years) with chronic low back pain (≥ 6 weeks, pain intensity ≥ 5/10 on a Numerical Rating Scale). Participants were randomized to a Fibranium topper (n=27) or a placebo topper (n=27) for 4 weeks. The primary outcome was the McGill Pain Questionnaire total score. Secondary outcomes included the Oswestry Disability Index, Linton-Halldén Score, Pittsburgh Sleep Quality Index, Short Form-36. Data were analyzed using linear models, with baseline scores as covariates. The Fibranium group showed significantly greater improvements in McGill total score (p = 0.000002), Oswestry Disability Index (p = 0.000005), Linton-Halldén Score (p = 0.000010), and SF-36 total score (p = 0.000001) compared to the placebo group. All SF-36 subscales except Emotional Wellbeing showed significant improvements. No significant difference was found in the Pittsburgh Sleep Quality Index total score; however, sleep latency (component 2) improved significantly in the Fibranium group (p = 0.000175). The Fibranium fiber mattress topper demonstrated significant efficacy in reducing pain and improving function in individuals with chronic low back pain. These findings support Fibranium as a non-pharmacological intervention for chronic low back pain.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.001 | 0.001 |
| Meta-epidemiology (narrow) | 0.001 | 0.001 |
| Meta-epidemiology (broad) | 0.004 | 0.002 |
| Bibliometrics | 0.001 | 0.000 |
| Science and technology studies | 0.001 | 0.001 |
| Scholarly communication | 0.001 | 0.001 |
| Open science | 0.001 | 0.000 |
| Research integrity | 0.002 | 0.002 |
| Insufficient payload (model declined to judge) | 0.007 | 0.001 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".